Derycke Lucie, Tomasi Jacques, Desgranges Pascal, Pesteil Francis, Plissonier Didier, Pernot Mathieu, Millon Antoine, Martinez Robert, Chakfe Nabil, Alsac Jean-Marc
Department of Cardio-Vascular and Vascular Surgery, Hôpital Européen Georges Pompidou, Paris, France.
Department of Thoracic and Cardiovascular Surgery, University Hospital Centre-INSERM LTSI 1099, Rennes, France.
Eur J Vasc Endovasc Surg. 2023 Dec;66(6):821-829. doi: 10.1016/j.ejvs.2023.08.002. Epub 2023 Aug 9.
A proximal scallop design allows aortic arch repair without complex endovascular manipulation in the aortic arch. The aim was to assess the safety and efficacy at one year of the Relay proximal scallop stent graft.
A prospective multicentre study evaluated consecutive patients treated with the Relay proximal scallop stent graft in 10 French aortic centres. All consecutive patients eligible for elective thoracic endovascular repair with proximal scallop in the 10 participating centres between January 2015 and July 2018 were included. Primary endpoints were 30 day mortality, stroke, and spinal cord ischaemia (SCI) rates. Outcomes including safety and efficacy, technical and clinical success, all cause death, neurological events, vessel patency, and device specific complications were analysed. Survival and survival without severe complications were estimated using Kaplan-Meier estimates.
Ten aortic centres treated 40 patients for thoracic aortic aneurysm (45%), penetrating atherosclerotic aneurysm (30%), and dissection (25%). Half of the procedures (50%) targeted zone 0 of the aortic arch (zone 0 in 17.5% and zones 0/1 in 32.5%), 37.5% targeted zone 2 (35% zone 2 alone; 2.5% zones 1/2), and 15% targeted zone 1 (12.5% zone 1 alone). Median follow up was one year. Thirty day mortality, stroke, and SCI rates were 10%, 5%, and 0% respectively. Primary technical success was 95%. Type Ia, Ib, and III endoleaks rates were 5.4%, 0%, and 0% respectively at one month. The overall mortality rate at one year was 17.5%. Aneurysm expansion was > 5 mm in one case at one year associated with type Ia endoleak (3%). There was no supra-aortic trunk thrombosis, one (2%) graft kink, and no migration.
One year outcomes showed that the Relay proximal scallop stent graft is an acceptable answer to thoracic aortic disease to deal with short proximal landing zones.
近端扇贝形设计允许在主动脉弓进行主动脉弓修复,而无需在主动脉弓进行复杂的血管内操作。目的是评估Relay近端扇贝形支架移植物一年时的安全性和有效性。
一项前瞻性多中心研究评估了法国10个主动脉中心连续接受Relay近端扇贝形支架移植物治疗的患者。纳入了2015年1月至2018年7月期间10个参与中心所有符合择期胸主动脉腔内修复且有近端扇贝形的连续患者。主要终点是30天死亡率、中风和脊髓缺血(SCI)发生率。分析了包括安全性和有效性、技术和临床成功率、全因死亡、神经事件、血管通畅性和器械特异性并发症等结果。使用Kaplan-Meier估计法估计生存率和无严重并发症的生存率。
10个主动脉中心治疗了40例胸主动脉瘤患者(45%)、穿透性动脉粥样硬化性动脉瘤患者(30%)和夹层患者(25%)。一半的手术(50%)针对主动脉弓的0区(17.5%为0区,32.5%为0/1区),37.5%针对2区(单独2区为35%;1/2区为2.5%),15%针对1区(单独1区为12.5%)。中位随访时间为一年。30天死亡率、中风和SCI发生率分别为10%、5%和0%。主要技术成功率为95%。1个月时Ia型、Ib型和III型内漏发生率分别为5.4%、0%和0%。一年时的总死亡率为17.5%。1例患者在一年时动脉瘤扩张>5 mm,与Ia型内漏有关(3%)。没有主动脉弓上干血栓形成,1例(2%)移植物扭结,没有移位。
一年的结果表明,Relay近端扇贝形支架移植物是处理胸主动脉疾病近端着陆区较短问题的一个可接受的解决方案。